The Price Is Right on NuScale, but Is It Cheap Enough to Make It a Buy?

NuScale Power stock is trading under $10 after once reaching about $57 in October 2025, leaving shares near a 52-week low. The article argues the company has a first-mover advantage in small modular reactors and cites a projected SMR market expansion from $8.1 billion in 2026 to $17.3 billion by 2035, but it also stresses that NuScale is still unprofitable and has not built any commercial reactors. The message is speculative and long-term in nature, with emphasis on patience and position sizing rather than a near-term catalyst.

Analysis

The market is treating SMR less like a utility-enabling infrastructure asset and more like a binary execution option, which is why the stock can re-rate so violently on sentiment rather than fundamentals. The second-order dynamic is that the “winner” is not necessarily the first design-approved vendor, but the company that can convert regulatory credibility into bankable project finance and an anchored customer base before capital markets demand proof. If AI-driven power demand remains the dominant macro narrative, SMR benefits from a rising-water effect across the nuclear complex, but that also raises the bar for differentiated execution versus better-capitalized peers and alternate clean-power solutions.

The key risk is time mismatch: the addressable market may expand over years, while equity holders must finance multiple quarters of dilution, headline volatility, and potentially incremental financing rounds before commercial revenue meaningfully scales. Under $10, the stock can look cheap on a chart, but the real risk/reward is dominated by milestone risk—any slip in customer conversion, construction economics, or policy support can compress the multiple further even if the long-term theme stays intact. Conversely, a credible FID, utility partnership, or government-backed deployment would likely trigger a sharp reflexive move because positioning is likely light and skeptical.

The contrarian view is that the current drawdown may be partly overdone if investors are extrapolating “pre-revenue” into “permanent zero,” especially in a market willing to pay for power-supply optionality. But the more useful framing is that SMR is a financing and commercialization story first, technology story second. In that sense, the upside is best captured through staged exposure or event-driven structures rather than a blunt cash equity entry.

Key Decisions for Investors

• Initiate a small starter long in SMR only on weakness below $10, sized at a fraction of a normal position; treat it as a 12-24 month venture-style option with a hard stop if commercialization milestones slip.
• Use a call spread in SMR (e.g., 6-12 month maturities) instead of common stock to define downside while preserving upside to a catalyst-driven rerate; best if you expect a project/partner announcement within two quarters.
• Pair long SMR vs short NRG or XLU only if you want pure policy/AI-power optionality; this isolates the idiosyncratic nuclear upside while hedging broad utility beta.
• If long already, add only after evidence of customer conversion or financing de-risking; do not average down mechanically because dilution risk can dominate price action for several quarters.
• Monitor for any utility offtake, DOE support, or regulatory/commercial milestones as the real catalyst window; absent those, expect the stock to remain range-bound with high volatility and weak carry.